Literature DB >> 8602265

Calcium mobilization via sphingosine kinase in signalling by the Fc epsilon RI antigen receptor.

O H Choi1, J H Kim, J P Kinet.   

Abstract

Calcium mobilization through antigen receptors, including high-affinity IgE receptors (Fc epsilon RI), is thought to be mediated by inositol-1,4,5-trisphosphate production (InsP3). Here we show that antigen clustering of Fc epsilon RI on the rat mast-cell line (RBL-2H3) activates a sphingosine kinase (SK) and produces sphingosine-1-phosphate (S1P), and alternative second messenger for intracellular calcium mobilization. The sphingosine analogue, D-L-threo-dihydrosphingosine (DHS), inhibits the SK enzyme competitively with a dissociation constant, K1, of 5 to 18 microM. This inhibition substantially suppresses the Fc epsilon RI-mediated calcium signal, but leaves intact the syk tyrosine kinase activation and the small InsP3 production. The entire InsP3-dependent pathway activated by a transfected G-protein coupled receptor, used here as a positive control, also remained intact. Thus Fc epsilon RI principally utilizes a SK pathway to mobilize calcium.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8602265     DOI: 10.1038/380634a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  87 in total

1.  Vav1 regulates phospholipase cgamma activation and calcium responses in mast cells.

Authors:  T S Manetz; C Gonzalez-Espinosa; R Arudchandran; S Xirasagar; V Tybulewicz; J Rivera
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

Review 2.  Deciphering the structure and function of FcεRI/mast cell axis in the regulation of allergy and anaphylaxis: a functional genomics paradigm.

Authors:  Jayapal Manikandan; Narasimhan Kothandaraman; Manoor Prakash Hande; Peter Natesan Pushparaj
Journal:  Cell Mol Life Sci       Date:  2011-12-07       Impact factor: 9.261

Review 3.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 4.  Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.

Authors:  Dong-Soon Im
Journal:  Acta Pharmacol Sin       Date:  2010-08-23       Impact factor: 6.150

5.  Expression of SphK1 impairs degranulation and motility of RBL-2H3 mast cells by desensitizing S1P receptors.

Authors:  Puneet S Jolly; Meryem Bektas; Kenneth R Watterson; Heidi Sankala; Shawn G Payne; Sheldon Milstien; Sarah Spiegel
Journal:  Blood       Date:  2005-03-01       Impact factor: 22.113

6.  Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway.

Authors:  P Xia; J R Gamble; K A Rye; L Wang; C S Hii; P Cockerill; Y Khew-Goodall; A G Bert; P J Barter; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

7.  Human eosinophil chemotaxis and selective in vivo recruitment by sphingosine 1-phosphate.

Authors:  Fiorentina Roviezzo; Francesco Del Galdo; Gianfranco Abbate; Mariarosaria Bucci; Bruno D'Agostino; Edson Antunes; Gianfranco De Dominicis; Luca Parente; Francesco Rossi; Giuseppe Cirino; Raffaele De Palma
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-14       Impact factor: 11.205

8.  Blockage of sphingosine-1-phosphate receptor 2 attenuates allergic asthma in mice.

Authors:  Soo-Jin Park; Dong-Soon Im
Journal:  Br J Pharmacol       Date:  2019-03-14       Impact factor: 8.739

Review 9.  The role of sphingosine-1-phosphate and its receptors in asthma.

Authors:  John J Ryan; Sarah Spiegel
Journal:  Drug News Perspect       Date:  2008-03

10.  Sphingosine kinase regulates oxidized low density lipoprotein-mediated calcium oscillations and macrophage survival.

Authors:  Johnny H Chen; Maziar Riazy; Shih Wei Wang; Jiazhen Minnie Dai; Vincent Duronio; Urs P Steinbrecher
Journal:  J Lipid Res       Date:  2009-11-05       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.